Giovanna Rotondo Dottore

Giovanna Rotondo Dottore

Auto-generated profile, based on publicly available information

Giovanna Rotondo Dottore

Endocrinology Unit I, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Thyroid®
Verified
Journal Article
Closed access
GDGiovanna Rotondo Dottore
Giovanna Rotondo Dottore
MLMarenza Leo
Marenza Leo
GCGiamberto Casini
Giamberto Casini
FLFrancesco Latrofa
Francesco Latrofa
LCLuca Cestari
Luca Cestari
Michele MarinoMichele Marino
Michele Marino
Background: A recent clinical trial has shown a beneficial effect of the antioxidant agent selenium in Graves' orbitopathy (GO). In order to shed light on the cellular mechanisms on which selenium may act, this study investigated its effects in cultured orbital fibroblasts. Methods: Primary cultures of orbital fibroblasts from six GO patients and six control subjects were established. Cells were treated with H 2 O 2 to induce oxidative stress, after pre-incubation with selenium-(methyl)selenocysteine (SeMCys). The following assays were performed: glutathione disulfide (GSSG), as a measure of oxidative stress, glutathione peroxidase (GPX) activity, cell proliferation, hyaluronic acid (HA), and pro-inflammatory cytokines. Results: H 2 O 2 induced an increase in cell GSSG and fibroblast proliferation, which were reduced by SeMCys. Incubation of H 2 O 2 -treated cells with SeMCys was followed by an increase in glutathione peroxidase activity, one of the antioxidant enzymes into which selenium is incorporated. At the concentrations used (5 μM), H 2 O 2 did not significantly affect HA release, but it was reduced by SeMCys. H 2 O 2 determined an increase in endogenous cytokines involved in the response to oxidative stress and GO pathogenesis, namely tumor necrosis factor alpha, interleukin 1 beta, and interferon gamma. The increases in tumor necrosis factor alpha and interferon gamma were blocked by SeMCys. While the effects of SeMCys on oxidative stress and cytokines were similar in GO and control fibroblasts, they were exclusive to GO fibroblasts in terms of inhibiting proliferation and HA secretion. Conclusions: Selenium, in the form of SeMCys, abolishes some of the effects of oxidative stress in orbital fibroblasts, namely increased proliferation and secretion of pro-inflammatory cytokines. SeMCys reduces HA release in GO fibroblasts in a manner that seems at least in part independent from H 2 O 2 -induced oxidative stress. Some effects of SeMCys are specific for GO fibroblasts. These findings reveal some cellular mechanisms by which selenium may act in patients with GO.

12 October 2016 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
MLM. Leo
M. Leo
LBL. Bartalena
L. Bartalena
GDG. Rotondo Dottore
G. Rotondo Dottore
EPE. Piantanida
E. Piantanida
PPP. Premoli
P. Premoli
Michele MarinoMichele Marino
Michele Marino

21 August 2018 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
Michele MarinoMichele Marino
Michele Marino
GDG. Rotondo Dottore
G. Rotondo Dottore
III. Ionni
I. Ionni
GLG. Lanzolla
G. Lanzolla
ESE. Sabini
E. Sabini
LCL. Chiovato
L. Chiovato

18 December 2017 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
GDG. Rotondo Dottore
G. Rotondo Dottore
III. Ionni
I. Ionni
FMF. Menconi
F. Menconi
GCG. Casini
G. Casini
SSS. Sellari-Franceschini
S. Sellari-Franceschini
Michele MarinoMichele Marino
Michele Marino

27 June 2017 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
GDG. Rotondo Dottore
G. Rotondo Dottore
III. Ionni
I. Ionni
FMF. Menconi
F. Menconi
GCG. Casini
G. Casini
SSS. Sellari-Franceschini
S. Sellari-Franceschini
Michele MarinoMichele Marino
Michele Marino

17 January 2017 in Endocrine
Verified
Journal Article
Closed access
PDF file
GDGiovanna Rotondo Dottore
Giovanna Rotondo Dottore
RCRiccardo Chiarini
Riccardo Chiarini
MGMaria De Gregorio
Maria De Gregorio
MLMarenza Leo
Marenza Leo
GCGiamberto Casini
Giamberto Casini
Michele MarinoMichele Marino
Michele Marino